Results 131 to 140 of about 12,104 (196)

Oncolytic virotherapy potentiates chemo-PD-1 immunotherapy by engaging chemo-resistant bystander CD8<sup>+</sup> T cells. [PDF]

open access: yesJ Immunother Cancer
Yang Y   +14 more
europepmc   +1 more source

Editorial: Oncolytic virotherapy, volume II. [PDF]

open access: yesFront Mol Biosci
Al-Shammari AM, Piccaluga PP.
europepmc   +1 more source

Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity. [PDF]

open access: yesJ Immunother Cancer
Hayes AJ   +18 more
europepmc   +1 more source

Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care. [PDF]

open access: yesVet Sci
Labé C   +15 more
europepmc   +1 more source

Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer. [PDF]

open access: yesSci Rep
Pannhausen J   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy